IP Library Assignment 027901/0231
Patent Assignment
Reel/Frame 027901/0231

Assignment of Assignor's Interest

Recorded: 2012-03-21 Pages: 9
Assignors
WILD, KENNETH D., JR.
Executed: 2004-09-27
TREANOR, JAMES J.S.
Executed: 2004-09-27
HUANG, HAICHUN
Executed: 2004-09-27
INOUE, HEATHER
Executed: 2004-09-30
ZHANG, TIE J.
Executed: 2004-09-27
MARTIN, FRANK
Executed: 2004-09-27
Assignee
AMGEN INC.
ONE AMGEN CENTER DRIVE, THOUSAND OAKS, CALIFORNIA, 91320
Covered Property (1)
Methods of Treating Conditions Caused by Increased Expression of Nerve Growth Factor (Ngf) or Increased Sensitivity to Ngf Using Anti-Ngf Neutralizing Antibodies as Selective Ngf Pathway Inhibitors
Patent: 9,260,514 →
Application: 12/576,522 →
Publication: US 2010/0034818
Related Assignments (3)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Mar 21, 2012
From: AMGEN INC.
To: AMGEN INC.; MEDAREX, INC.
Reel/Frame 027901/0253 →
Merger Aug 15, 2013
From: MEDAREX, INC.
To: MEDAREX, L.L.C.
Reel/Frame 031016/0678 →
Merger May 22, 2015
From: MEDAREX, L.L.C.
To: E. R. SQUIBB & SONS, L.L.C.
Reel/Frame 035695/0204 →